Skip to content

A Cohort Study of Uterine Malignancies

A Cohort Study of Uterine Malignancies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05635123
Enrollment
6200
Registered
2022-12-02
Start date
2023-09-15
Completion date
2030-12-01
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer, Endometrial Cancer

Brief summary

The purposes of current study were to explore the relationship between cervical cancer/endometrial cancer and demographic information, behavior and life style, pregnancy-related factors, and disease history, and to study the factors affecting the prognosis of cancers. In addition, omics tests were performed on the biological specimens to identify the diagnostic markers and prognostic biomarkers.

Detailed description

After being informed about the study and potential risks, all patients who meet the eligibility requirements will be enrolled.

Interventions

OTHERNo intervention

This is a prospective observational study with no intervention.

Sponsors

Women's Hospital School Of Medicine Zhejiang University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age 20-75 years; * Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time; * Women attending a health check-up; * Obtain informed consent and sign an informed consent form.

Exclusion criteria

* Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment; * Patients with cancer other than cervical cancer or endometrial cancer; * Women who have received hysterectomy or pelvic radiation therapy previously.

Design outcomes

Primary

MeasureTime frameDescription
progression free survival (PFS)60 monthsprogression free survival for patients with cervical cancer or endometrial cancer

Countries

China

Contacts

Primary ContactHui Wang, PhD
wang71hui@zju.deu.cn0571-89998857
Backup ContactXiao Li, PhD
5198009@zju.edu.cn13958160137

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026